J.Jill Full Year 2025 Earnings: EPS Misses Expectations

Simply Wall St

April 03, 2025

J.Jill (NYSE:JILL) Full Year 2025 Results

Key Financial Results

Revenue: US$610.9m (flat on FY 2024).
Net income: US$39.5m (up 9.1% from FY 2024).
Profit margin: 6.5% (up from 6.0% in FY 2024).
EPS: US$2.64 (up from US$2.56 in FY 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

JILL Sales Performance

Like-for-like sales growth: 1.5% vs FY 2024.

revenue-and-expenses-breakdown — NYSE:JILL Revenue and Expenses Breakdown April 3rd 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

J.Jill EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 15%.

In the last 12 months, the only revenue segment was Retail and Direct Channels contributing US$610.9m. The largest operating expense was General & Administrative costs, amounting to US$274.9m (70% of total expenses). Explore how JILL's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 2.6% p.a. on average during the next 2 years, compared to a 5.0% growth forecast for the Specialty Retail industry in the US.

Performance of the American Specialty Retail industry.

The company's shares are down 3.7% from a week ago.

Risk Analysis

Be aware that J.Jill is showing 2 warning signs in our investment analysis and 1 of those is potentially serious...

If you're looking to trade J.Jill, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.